ALSTON & BIRD LLP for NOVO NORDISK INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General diabetes prevention; H.R. 309/S. 920 Clinical Care Commission Act; H.R. 1628 American Health Care Act (AHCA) and Better Care Reconciliation Act of 2017; World Hemophilia Day; Growth Awareness Week; National Obesity Care Week, H.Res. 142/S.Res. 63; H.R. 3921 Healthy Kids Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON CAMPAGNA New | — |
| STEPHANIE CURTIS New | — |
| JOYCE E GRESKO | — |
| Y. BRIAN LEE | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| TIMOTHY P TRYSLA | — |
| MARILYN K YAGER | — |
Taxation/Internal Revenue Code TAX
Comprehensive corporate tax reform, including border adjustment tax and interest deductibility.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Medicare/Medicaid MMM
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D; H.R. 849/S. 260 Protecting Seniors Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 1542 Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act (HELLPP Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON CAMPAGNA New | — |
| STEPHANIE CURTIS New | — |
| JOYCE E GRESKO | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| TIMOTHY P TRYSLA | — |
| MARILYN K YAGER | — |
Budget/Appropriations BUD
H.R.2953, To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; National Diabetes Prevention Program and other CDC diabetes prevention activities in FY 2018 Labor, Health and Human Services, and Education Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| Y. BRIAN LEE | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Pharmacy PHA
Issues related to H.R. 2430/S. 934 FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| Y. BRIAN LEE | — |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.